Subsequent to the discovery of the CC2D1A as one of the constituent members of the 14-gene panel predicting early recurrence in ovarian cancer (15), we hypothesized that CC2D1A has a role in modulating chemoresistance of ovarian cancer. The gene discussed is CC2D1A; the disease is ovarian cancer.